ZOLNUM
Natural health product licensed in Canada
- Licence holder
- Zolar Technology & MFG Co. Inc.
- NPN or DIN-HM
- 80091860
- Status
- Active licence
- Licence date
- 18 April 2019
- Revision date
- Not provided
- Form
- Gel
- Route of administration
- Topique
- Application type
- Non traditionnelle
Oral dose analysis does not apply without an established exclusively oral route.
Composition
Medicinal composition not provided.
Non-medicinal ingredients
Saveur de menthe, Parahydroxybenzoate de méthyle, Carbomer 934P, Sodium Saccharin, propylèneglycol, PEG-400, Povidone, Eau purifiée, FD & C bleu #1, Alcool éthylique, Propyl paraben, Jaune D & C No. 10
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Enfants | minimum: 2 years | 0.2 mL | 1 Tous les jours |
| Adultes | Not specified | 0.2 mL | 1 Tous les jours |
Uses authorised in Canada
Text supplied in English because no French text is available.
Zolnum is a topical anesthetic gel used for rapid topical anesthesia.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Warnings are available in English on the official record.
Source
Official Health Canada record, licence 80091860
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.